Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Cancer Causes & Control
Published in: Cancer Causes & Control 7/2016

01-07-2016 | Original paper

Dietary inflammatory index and ovarian cancer risk in a large Italian case–control study

Authors: Nitin Shivappa, James R. Hébert, Valentina Rosato, Marta Rossi, Maurizio Montella, Diego Serraino, Carlo La Vecchia

Published in: Cancer Causes & Control | Issue 7/2016

Login to get access

Abstract

Background

While inflammation has been shown to play an important etiologic role in ovarian carcinogenesis, little is known about the association between inflammatory properties of diet and ovarian cancer risk.

Methods

We explored the association between the dietary inflammatory index (DII) and ovarian cancer risk in a multicentric Italian case–control study conducted between 1992 and 1999. Cases were 1,031 women with incident, histologically confirmed ovarian cancer from four areas in Italy. Controls were 2,411 women admitted to the same network of hospitals as the cases for acute, non-malignant and non-gynecological conditions, unrelated to hormonal or digestive-tract diseases or committed to long-term modifications of diet. DII scores were computed based on 31 nutrients and food items assessed using a reproducible and validated 78-item food frequency questionnaire. Odds ratios (ORs) were estimated through logistic regression models adjusting for age, total energy intake and other recognized confounding factors.

Results

Subjects in the highest quartile of DII scores (i.e., with the most pro-inflammatory diets) had a higher risk of ovarian cancer compared to subjects in the lowest quartile (i.e., with an anti-inflammatory diet) (ORQuartile4vs1 1.47, 95% confidence interval, CI, 1.07, 2.01; p trend = 0.009). When analyses were carried out using continuous DII, a significant positive association with ovarian cancer was observed: the OR for one-unit increment in DII score (corresponding to approximately 8 % of its range in the current study, +6.0 to −6.20) was 1.08 (95% CI 1.02, 1.14).

Conclusion

A pro-inflammatory diet as indicated by higher DII scores is associated with increased ovarian cancer risk.
Literature
1.
Ferlay JSI, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F (2012) GLOBOCAN 2012 v1.1, Cancer incidence and mortality worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: Available from: http://​globocan.​iarc.​fr
2.
American Cancer Society (2015) Cancer Facts & Figures
3.
Holschneider CH, Berek JS (2000) Ovarian cancer: epidemiology, biology, and prognostic factors. Semin Surg Oncol 19(1):3–10. PubMed PMID: 10883018
4.
Olsen CM, Green AC, Whiteman DC, Sadeghi S, Kolahdooz F, Webb PM (2007) Obesity and the risk of epithelial ovarian cancer: a systematic review and meta-analysis. Eur J Cancer 43(4):690–709CrossRefPubMed
5.
World Cancer Research Fund International/American Institute for Cancer Research (2014) Continuous update project report summary. Food, nutrition, physical activity, and the prevention of ovarian cancer
6.
Ness RB, Cottreau C (1999) Possible role of ovarian epithelial inflammation in ovarian cancer. J Natl Cancer Inst 91(17):1459–1467CrossRefPubMed
7.
Ose J, Schock H, Tjonneland A, Hansen L, Overvad K, Dossus L, et al. (2015) Inflammatory markers and risk of epithelial ovarian cancer by tumor subtypes: the EPIC Cohort. Cancer epidemiology, biomarkers and prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 24(6):951–961. PubMed PMID: 25855626. Pubmed Central PMCID: 4454588
8.
Shivappa N, Steck SE, Hurley TG, Hussey JR, Hebert JR (2014) Designing and developing a literature-derived, population-based dietary inflammatory index. Publ Health Nutr 17(8):1689–1696. PubMed PMID: 23941862. Pubmed Central PMCID: 3925198
9.
Shivappa N, Steck SE, Hurley TG, Hussey JR, Ma Y, Ockene IS, et al. (2014) A population-based dietary inflammatory index predicts levels of C-reactive protein in the Seasonal Variation of Blood Cholesterol Study (SEASONS). Publ Health Nutr 17(8):1825–1833. PubMed PMID: 24107546. Pubmed Central PMCID: 3983179
10.
Shivappa N, Hebert JR, Rietzschel ER, De Buyzere ML, Langlois M, Debruyne E, et al. (2015) Associations between dietary inflammatory index and inflammatory markers in the Asklepios Study. Br J Nutr 113(4):665–671. PubMed PMID: 25639781. Pubmed Central PMCID: 4355619
11.
Tabung FK, Steck SE, Zhang J, Ma Y, Liese AD, Agalliu I, et al. (2015) Construct validation of the dietary inflammatory index among postmenopausal women. Annal Epidemiol 25(6):398–405. PubMed PMID: 25900255. Pubmed Central PMCID: 4433562
12.
Zamora-Ros R, Shivappa N, Steck SE, Canzian F, Landi S, Alonso MH, et al. (2015) Dietary inflammatory index and inflammatory gene interactions in relation to colorectal cancer risk in the Bellvitge colorectal cancer case–control study. Genes Nutr 10(1):447. PubMed PMID: 25488145. Pubmed Central PMCID: 4259879
13.
Shivappa N, Zucchetto A, Montella M, Serraino D, Steck SE, La Vecchia C et al (2015) Inflammatory potential of diet and risk of colorectal cancer: a case–control study from Italy. Br J Nutr 114(1):152–158CrossRefPubMed
14.
Tabung FK, Steck SE, Ma Y, Liese AD, Zhang J, Caan B, et al. (2015) The association between dietary inflammatory index and risk of colorectal cancer among postmenopausal women: results from the Women’s Health Initiative. Cancer Causes Control 26(3):399–408. PubMed PMID: 25549833. Pubmed Central PMCID: 4334706
15.
Wirth MD, Shivappa N, Steck SE, Hurley TG, Hebert JR (2015) The dietary inflammatory index is associated with colorectal cancer in the National Institutes of Health-American Association of Retired Persons Diet and Health Study. Br J Nutr 113(11):1819–1827. PubMed PMID: 25871645. Pubmed Central PMCID: 4466003
16.
Shivappa N, Prizment AE, Blair CK, Jacobs DR, Jr., Steck SE, Hebert JR (2014) Dietary inflammatory index and risk of colorectal cancer in the Iowa Women’s Health Study. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 23(11):2383–2392. PubMed PMID: 25155761. Pubmed Central PMCID: 4221503
17.
Shivappa N, Bosetti C, Zucchetto A, Montella M, Serraino D, La Vecchia C, et al. (2014) Association between dietary inflammatory index and prostate cancer among Italian men. Br J Nutr 17:1–6. PubMed PMID: 25400225. Pubmed Central PMCID: 4433863
18.
Shivappa N, Bosetti C, Zucchetto A, Serraino D, La Vecchia C, Hebert JR (2014) Dietary inflammatory index and risk of pancreatic cancer in an Italian case–control study. Br J Nutr 17:1–7. PubMed PMID: 25515552. Pubmed Central PMCID: 4470878
19.
Shivappa N, Zucchetto A, Serraino D, Rossi M, La Vecchia C, Hebert JR (2015) Dietary inflammatory index and risk of esophageal squamous cell cancer in a case–control study from Italy. Cancer Causes Control 26(10):1439–1447CrossRefPubMed
20.
Shivappa N, Hebert JR, Polesel J, Zucchetto A, Crispo A, Montella M et al (2015) Inflammatory potential of diet and risk for hepatocellular cancer in a case–control study from Italy. Br J Nutr 11:1–8
21.
Shivappa N, Hébert JR, Zucchetto A, Montella M, Serraino D, La Vecchia C, et al. (2015) Dietary inflammatory index and endometrial cancer risk in an Italian case–control study. Br J Nutr FirstView:1–9
22.
Bosetti C, Negri E, Franceschi S, Pelucchi C, Talamini R, Montella M et al (2001) Diet and ovarian cancer risk: a case–control study in Italy. Int J Cancer J Int du Cancer 93(6):911–915CrossRef
23.
Salvini S, Parpinel M, Gnagnarella P, Maisonneuve P, Turrini A (1998) Banca dati di composizione degli alimenti per studi epidemiologici in Italia. Istituto Europeo di Oncologia, Milano
24.
Decarli A, Franceschi S, Ferraroni M, Gnagnarella P, Parpinel MT, La Vecchia C, et al. (1996) Validation of a food-frequency questionnaire to assess dietary intakes in cancer studies in Italy. Results for specific nutrients. Ann Epidemiol. 6(2):110–118. PubMed PMID: 8775590. Epub 1996/03/01. eng
25.
Franceschi S, Negri E, Salvini S, Decarli A, Ferraroni M, Filiberti R, et al. (1993) Reproducibility of an Italian food frequency questionnaire for cancer studies: results for specific food items. Eur J Cancer 29A(16):2298–2305. PubMed PMID: 8110502. Epub 1993/01/01. eng
26.
Franceschi S, Barbone F, Negri E, Decarli A, Ferraroni M, Filiberti R, et al. (1995) Reproducibility of an Italian food frequency questionnaire for cancer studies. Results for specific nutrients. Ann Epidemiol 5(1):69–75. PubMed PMID: 7728288. Epub 1995/01/01. eng
27.
Rossi M, Negri E, Lagiou P, Talamini R, Dal Maso L, Montella M et al (2008) Flavonoids and ovarian cancer risk: a case–control study in Italy. Int J Cancer J Int du Cancer 123(4):895–898CrossRef
28.
Bidoli E, La Vecchia C, Talamini R, Negri E, Parpinel M, Conti E et al (2001) Micronutrients and ovarian cancer: a case–control study in Italy. Annal Oncol Off J Eur Soc Med Oncol/ESMO 12(11):1589–1593CrossRef
29.
Pelucchi C, La Vecchia C, Chatenoud L, Negri E, Conti E, Montella M et al (2001) Dietary fibres and ovarian cancer risk. Eur J Cancer 37(17):2235–2239CrossRefPubMed
30.
Bidoli E, La Vecchia C, Montella M, Maso LD, Conti E, Negri E et al (2002) Nutrient intake and ovarian cancer: an Italian case–control study. Cancer Causes Control 13(3):255–261CrossRefPubMed
31.
Augustin LS, Polesel J, Bosetti C, Kendall CW, La Vecchia C, Parpinel M et al (2003) Dietary glycemic index, glycemic load and ovarian cancer risk: a case–control study in Italy. Annal Oncol Off J Eur Soc Med Oncol/ESMO 14(1):78–84CrossRef
32.
Chandran U, Bandera EV, Williams-King MG, Paddock LE, Rodriguez-Rodriguez L, Lu SE, et al. (2011) Healthy eating index and ovarian cancer risk. Cancer Causes Control 22(4):563–571. PubMed PMID: 21286802. Pubmed Central PMCID: 3131161
33.
Gifkins D, Olson SH, Paddock L, King M, Demissie K, Lu SE, et al. (2012) Total and individual antioxidant intake and risk of epithelial ovarian cancer. BMC Cancer 12:211. PubMed PMID: 22656322. Pubmed Central PMCID: 3406971
34.
Tasevska N, Jiao L, Cross AJ, Kipnis V, Subar AF, Hollenbeck A, et al. (2012) Sugars in diet and risk of cancer in the NIH-AARP Diet and Health Study. Int J Cancer J Int du Cancer 130(1):159-69. PubMed PMID: 21328345. Pubmed Central PMCID: 3494407
35.
King MG, Olson SH, Paddock L, Chandran U, Demissie K, Lu SE, et al. (2013) Sugary food and beverage consumption and epithelial ovarian cancer risk: a population-based case–control study. BMC Cancer. 13:94. PubMed PMID: 23442818. Pubmed Central PMCID: 3598848
36.
Silvera SA, Jain M, Howe GR, Miller AB, Rohan TE (2007) Glycaemic index, glycaemic load and ovarian cancer risk: a prospective cohort study. Publ Health Nutr 10(10):1076–1081CrossRef
37.
Turati F, Galeone C, Gandini S, Augustin LS, Jenkins DJ, Pelucchi C et al (2015) High glycemic index and glycemic load are associated with moderately increased cancer risk. Mol Nutr Food Res 59(7):1384–1394CrossRefPubMed
38.
Trabert B, Pinto L, Hartge P, Kemp T, Black A, Sherman ME, et al. (2014) Pre-diagnostic serum levels of inflammation markers and risk of ovarian cancer in the prostate, lung, colorectal and ovarian cancer (PLCO) screening trial. Gynecol Oncol 135(2):297–304. PubMed PMID: 25158036. Pubmed Central PMCID: 4254357
39.
Poole EM, Lee IM, Ridker PM, Buring JE, Hankinson SE, Tworoger SS (2013) A prospective study of circulating C-reactive protein, interleukin-6, and tumor necrosis factor alpha receptor 2 levels and risk of ovarian cancer. Am J Epidemiol 178(8):1256–1264. PubMed PMID: 23966559. Pubmed Central PMCID: 3792725
40.
Dong Y, Li J, Han F, Chen H, Zhao X, Qin Q et al (2015) High IGF2 expression is associated with poor clinical outcome in human ovarian cancer. Oncol Rep 34(2):936–942PubMed
41.
Schock H, Fortner RT, Surcel HM, Grankvist K, Pukkala E, Lehtinen M, et al. (2015) Early pregnancy IGF-I and placental GH and risk of epithelial ovarian cancer: a nested case–control study. Int J Cancer J Int du Cancer 137(2):439–447. PubMed PMID: 25516257. Pubmed Central PMCID: 4428944
42.
Renehan AG, Zwahlen M, Minder C, O’Dwyer ST, Shalet SM, Egger M (2004) Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet 363(9418):1346–1353. PubMed PMID: WOS:000220996300008. English
43.
Bruchim I, Werner H (2013) Targeting IGF-1 signaling pathways in gynecologic malignancies. Expert Opin Ther Tar 17(3):307–320. PubMed PMID: WOS:000314851700008. English
44.
Wang Y, Li LZ, Guo XQ, Jin X, Sun WJ, Zhang XL, et al. (2012) Interleukin-6 signaling regulates anchorage-independent growth, proliferation, adhesion and invasion in human ovarian cancer cells. Cytokine 59(2):228–236. PubMed PMID: WOS:000306159200008. English
45.
Chen YW, Apostolakis S, Lip GY (2014) Exercise-induced changes in inflammatory processes: implications for thrombogenesis in cardiovascular disease. Ann Med 46(7):439–455CrossRefPubMed
46.
Pettit LK, Varsanyi C, Tadros J, Vassiliou E (2013) Modulating the inflammatory properties of activated microglia with Docosahexaenoic acid and Aspirin. Lipids Health Dis 12:16. PubMed PMID: 23398903. Pubmed Central PMCID: 3663775
47.
Brasky TM, Liu J, White E, Peters U, Potter JD, Walter RB et al (2014) Non-steroidal anti-inflammatory drugs and cancer risk in women: results from the Women’s Health Initiative. Int J Cancer J Int du Cancer 135(8):1869–1883CrossRef
48.
Abbott SE, Bandera EV, Qin B, Peres LC, Moorman PG, Barnholtz-Sloan J, et al. (2016) Recreational physical activity and ovarian cancer risk in African American women. Cancer Med. PubMed PMID: 26923432
49.
Tavani A, Gallus S, La Vecchia C, Conti E, Montella M, Franceschi S (2000) Aspirin and ovarian cancer: an Italian case–control study. Annal Oncol Off J Eur Soc Med Oncol/ESMO 11(9):1171–1173CrossRef
50.
Tavani A, Gallus S, La Vecchia C, Dal Maso L, Negri E, Pelucchi C et al (2001) Physical activity and risk of ovarian cancer: an Italian case–control study. Int J Cancer J Int du Cancer 91(3):407–411CrossRef
Metadata
Title
Dietary inflammatory index and ovarian cancer risk in a large Italian case–control study
Authors
Nitin Shivappa
James R. Hébert
Valentina Rosato
Marta Rossi
Maurizio Montella
Diego Serraino
Carlo La Vecchia
Publication date
01-07-2016
Publisher
Springer International Publishing
Published in
Cancer Causes & Control / Issue 7/2016
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-016-0767-9

Other articles of this Issue 7/2016

Cancer Causes & Control 7/2016 Go to the issue

Original paper

Comparison of abdominal adiposity and overall obesity in relation to risk of small intestinal cancer in a European Prospective Cohort

Original paper

Maternal prenatal intake of one-carbon metabolism nutrients and risk of childhood leukemia

Erratum

Erratum to: Patterns and correlates of accelerometer-assessed physical activity and sedentary time among colon cancer survivors

Brief report

Associations of an abnormal Pap test result with attitudes and beliefs relevant to cervical cancer: a study of rural Appalachian women

Original Paper

Dietary inflammatory index, Mediterranean diet score, and lung cancer: a prospective study

Original paper

Fluoride exposure in public drinking water and childhood and adolescent osteosarcoma in Texas
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits